RxDoctor Payments Data

Rudolph Tovar, MD

Obstetrics & Gynecology · Lewisville, TXNPI 1790796662

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $701 of the $801 with a category attached, or 87.5%. It is spread thinly across 19 manufacturers, the largest accounting for just 20.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $257 and has fallen 77.4% since, to $58 in 2025. That places this record below the midpoint for obstetrics & gynecology clinicians in TX, where the typical reported total is $863.

$801in general payments, 2019–2025

Across 41 payments — averaging $19.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$164
  • Astellas Pharma US Inc$129
  • Pfizer$121
  • Coopersurgical, Inc.$51
  • Sumitomo Pharma America, Inc.$43
  • Therapeuticsmd, Inc.$41
  • plus $252 from 13 others

What the payments were for

  • Food & beverage$70188%
  • Education$10012%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$801 in reported general payments places this provider in the 45th percentile of 3,099 obstetrics & gynecology providers in Texas.

See all obstetrics & gynecology providers in Texas →

Medicare billing

Part B allowed, 2024
$18,500
Medicare patients
93
Services billed
224

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol94$3,360
Medroxyprogesterone Acetate34$358
JunelNorethindrone Ac/Eth Estradiol23$342
SprintecNorgestimate-Ethinyl Estradiol11$199
ValacyclovirValacyclovir Hcl11$103
Alendronate Sodium20$93
Clonazepam12$26

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Lewisville

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →